ANTI-JO-1 ANTIBODY-ASSOCIATED CLINICALLY AMYOPATHIC DERMATOMYOSITIS WITH RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE

被引：0
|
作者：
Naeem, Ifrah
Janga, Chaitra
Khan, Aamna
Muhammad, Malik
Khan, Uzair
Patel, Rajesh R.
Sadiq, Usama
Okoyeze, Kimberley
Kramer, Mackenzie
Patel, Tirth
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.1034
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1295A / 1296A
页数：2
相关论文
共 50 条
  • [41] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
    So, Ho
    Wong, Victor Tak Lung
    Lao, Virginia Weng Nga
    Pang, Hin Ting
    Yip, Ronald Man Lung
    CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1983 - 1989
  • [42] Anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease treated with therapeutic plasma exchange: A case series
    Saito, Tomohiro
    Mizobuchi, Masahide
    Miwa, Yusuke
    Sugiyama, Motonori
    Mima, Yuuki
    Iida, Ayana
    Kanazawa, Nobuhiro
    Morikawa, Tomoki
    Hayashi, Junichi
    Fukuda, Kei
    Shikida, Yasuto
    Suzuki, Taihei
    Honda, Hirokazu
    JOURNAL OF CLINICAL APHERESIS, 2021, 36 (01) : 196 - 205
  • [43] Rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis triggered by a 23-valent pneumococcal polysaccharide vaccine
    Suzuki, Koji
    Akiyama, Mitsuhiro
    Kondo, Yasushi
    Saito, Shuntaro
    Kikuchi, Jun
    Hanaoka, Hironari
    Kaneko, Yuko
    AUTOIMMUNITY REVIEWS, 2023, 22 (05)
  • [44] Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease
    Nara, Mizuho
    Komatsuda, Atsushi
    Omokawa, Ayumi
    Togashi, Masaru
    Okuyama, Shin
    Sawada, Ken-ichi
    Wakui, Hideki
    MODERN RHEUMATOLOGY, 2014, 24 (04) : 633 - 636
  • [45] POLYMYOSITIS WITH INTERSTITIAL LUNG-DISEASE ASSOCIATED WITH THE ANTI-JO-1 ANTIBODY PRESENTING AS THE SHRINKING LUNGS SYNDROME
    HARRIS, MD
    MCDONNELL, K
    TOMSKI, S
    WINN, BE
    ARTHRITIS AND RHEUMATISM, 1994, 37 (06): : R7 - R7
  • [46] The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level
    Osawa, Takeshi
    Morimoto, Kozo
    Sasaki, Yuka
    Matsuda, Shuichi
    Yamana, Kazunari
    Yano, Ryozo
    Uchiyama, Takashi
    Goto, Hajime
    INTERNAL MEDICINE, 2018, 57 (03) : 387 - 391
  • [47] Clinical Differences Between Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis and Classic Dermatomyositis
    Mukae, Hiroshi
    Ishimoto, Hiroshi
    Sakamoto, Noriho
    Hara, Shintaro
    Kakugawa, Tomoyuki
    Nakayama, Seiko
    Ishimatsu, Yuji
    Kawakami, Atsushi
    Eguchi, Katsumi
    Kohno, Shigeru
    CHEST, 2009, 136 (05) : 1341 - 1347
  • [48] COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report
    Cao, Mengke
    Zhang, Shuangshuang
    Chu, Dejie
    Xiao, Ming
    Liu, Xiaohong
    Yu, Lingling
    Li, Jing
    Huang, Yi
    Fang, Fang
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [49] COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report
    Mengke Cao
    Shuangshuang Zhang
    Dejie Chu
    Ming Xiao
    Xiaohong Liu
    Lingling Yu
    Jing Li
    Yi Huang
    Fang Fang
    BMC Pulmonary Medicine, 20
  • [50] Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis
    Miyazaki, Eishi
    Ando, Masaru
    Muramatsu, Tomoko
    Fukami, Tetsujiro
    Matsuno, Osamu
    Nureki, Shin-ichi
    Ueno, Takuya
    Tsuda, Tomiyasu
    Kumamoto, Toshihide
    CLINICAL RHEUMATOLOGY, 2007, 26 (03) : 436 - 439
12345